Paris, France - Jul 20, 2024: From a point-of-view perspective, a male hand holds an iPhone showing a CrowdStrike webpage about their role in addressing a major global IT outage, against a magenta — Stock Editorial Photography

What the ExtraHop Deal Means for CrowdStrike

Paris, France - Jul 20, 2024: From a point-of-view perspective, a male hand holds an iPhone showing a CrowdStrike webpage about their role in addressing a major global IT outage, against a magenta — Stock Editorial Photography

On April 30, 2025, CrowdStrike Holdings Inc. (NASDAQ: CRWD) announced it was expanding its partnership with ExtraHop. The two companies had already been working together to help enterprises detect and contain the shadow risks posed by artificial intelligence (AI).

Deals like this are popping up throughout the cybersecurity sector. But does this deal make CRWD stock stand out, or is it just one of many in a crowded field?

Many investors are flocking to cybersecurity stocks because of the threats from AI. The many benefits of AI come with the risk that bad actors can use the technology for malicious purposes. In January 2025, the World Economic Forum reported that approximately 50% of organizations cited Generative AI as their top concern.

That makes cybersecurity essential to corporations. For their part, cybersecurity companies are racing to incorporate AI capabilities into their product offerings.

CrowdStrike and ExtraHop Tackle a Shadow Threat

Shadow AI is exactly what it sounds like. These are tools that exist outside the visibility of traditional information technology (IT) and security teams. By bypassing these established security controls, they create blind spots that bad actors can use to access sensitive data or introduce misconfigurations that lead to breaches.

Under this expanded partnership, CrowdStrike’s Falcon Next-Gen SIEM platform will be able to ingest ExtraHop’s cloud-native network detection and response (NDR) platform, RevealX. This will give a company’s Security Operations Center real-time visibility into unauthorized AI service usage and the ability to act autonomously to protect sensitive data.

AI Is Causing CrowdStrike to Streamline Operations

CrowdStrike isn’t just using AI to enhance the services it offers to its customers. It is also using AI to streamline its own operations. On May 7, 2025, CrowdStrike announced it would cut approximately 5% of its global workforce (about 500 employees). 

The company says the cuts are part of a strategic initiative to become more efficient and assist it in achieving its goal of achieving $10 billion in annual recurring revenue (ARR) by January 2026.

It also illustrates the side of AI that is less comfortable for investors: that AI will be replacing a portion of the workforce. In the press release that accompanied the announcement, CrowdStrike acknowledged that AI flattens its hiring curve. However, CrowdStrike says it will continue hiring in critical areas. The company pointed out customer-facing and product engineering roles.

Investors should note that the layoffs will result in a charge between $36 million and $53 million, of which $7 million will be recorded in the current quarter. That means those charges won’t be reflected in the company’s upcoming earnings report. The majority of those costs will go toward severance, benefits, and stock-based compensation.

The Good and the Bad Heading Into Earnings

CrowdStrike doesn’t report its quarterly earnings until June, but investors may be getting a hint from analysts. Through the first eight days of May, the CrowdStrike analyst forecasts on MarketBeat show that four analysts have reiterated their bullish ratings and, in the case of JMP Securities, raised the price target from $400 to $500. And Rosenblatt Securities reiterated a price target of $450.

Both targets are significantly higher than the $403 consensus price targetAt $450, CRWD stock would be on track to make a new all-time high (ATH). That suggests that analysts believe CrowdStrike is preparing to deliver a strong earnings report. It could also mean investors may want to wait for a slight pullback before taking or adding to a position.

But here’s why investors may want to wait. Even among technology stocks, CrowdStrike shares are significantly overvalued at its current level. By itself, that’s not a dealbreaker. However, analysts forecast an approximate 12% decline in the company’s earnings per share (EPS). That would suggest that investors may not want to pay a premium valuation for CRWD stock.

Learn more about CRWD

Newest Stories

Industry 4.0 technology concept representing fourth industrial revolution.
3 Stocks Quietly Powering the AI and Tech Revolution

Artificial intelligence continues to dominate investor attention—and with good reason. But as valuations swell and pullbacks emerge, smart money is shifting toward the infrastructure names quietly powering the trend behind the scenes. In a recent conversation with analyst Marc Chaikin of Ch...

Bridget Bennett | Nov 14, 2025

Circuit boards are arranged over multiple Broadcom logos, highlighting semiconductor chip market dynamics.
Jefferies Tells NVIDIA to Step Aside, Picks Broadcom as Top Semiconductor Stock

Semiconductor giant Broadcom (NASDAQ: AVGO) has had a very strong 2025. As of the Nov. 13 close, shares have provided a total return of 47% on the year. This handily beats out the 16% return of the S&P 500 Index. Broadcom is also outperforming the semiconductor industry, as evidenced by th...

Leo Miller | Nov 14, 2025

Mobile phone with Fiserv stock performance displaying.
Fiserv Has NEVER Done This Before—Is It a Screaming Buy?

Fintech stock Fiserv Inc. (NASDAQ: FISV) has been going through one of its sharpest selloffs ever. Shares have fallen almost 50% in two weeks, adding to an already horrendous year, and sending the stock back to 2017 price levels. Fiserv shares are now down roughly 70% from March’s all-time h...

Sam Quirke | Nov 14, 2025

Lilly logo positioned in front of Lilly's weight loss drug, mounjaro.
Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since

The world’s most valuable healthcare stock, Eli Lilly and Company (NYSE: LLY), just dropped huge news. Like Pfizer (NYSE: PFE), Lilly announced a drug pricing deal with the Trump Administration. Below, we’ll break down what this means for Lilly going forward, as well as how the ma...

Leo Miller | Nov 14, 2025

TickerTalk Unveils Real-Time Financial Insights and Breaking News!